contadores web
Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Scientific and technological research article

Vol. 19 No. 3 (2017)

Predisposing factors for neonatal jaundice in patients discharged from neonatal ICU, in los Ángeles children’s Hospital in Pasto

DOI
https://doi.org/10.22267/rus.171903.97
Submitted
June 18, 2017
Published
2017-12-06

Abstract

Introduction: Neonatal jaundice is one of the most common conditions in newborns; however, improper treatment can be harmful to the patient, despite being benign. Objective: To determine the predisposing factors of neonatal jaundice in patients discharged from the neonatal ICU of Los Angeles children's Hospital in the city of Pasto (Nariño) between January 2007and August 2011. Materials and methods: An observational, descriptive, retrospective and quantitative study was conducted. 608 clinical histories of discharged infants diagnosed with neonatal jaundice were studied. The variables studied were analyzed with the complement of Excel, XLSTAT-Pro 7.5.2. Results: The main predisposing factors found in the population were exclusive breastfeeding and male gender in 87%, and 57.40% respectively; besides, 90.79% were newborns at term, 92.93% had adequate weight for their gestational age and 54.93% presented neonatal jaundice between 2 and 7 days of extrauterine life. Conclusions: Neonatal jaundice is associated with both modifiable and non-modifiable maternal and neonatal factors that can be addressed with appropriate strategies to reduce the burden of disease.

References

  1. Lauer BJ, Spector ND. Hyperbilirubinemia in the Newborn. Pediatr Rev. 2011;32(8):341-9.
  2. Gallegos-Dávila JA, Rodríguez-Balderrama I, Rodríguez-Bonito R, Abrego-Moya V, Rodríguez-Camelo G. Prevalencia y factores de riesgo para hiperbilirrubinemia indirecta neonatal en un hospital universitario. Med Univ. 2009;11(45):226-30.
  3. Wong RJ, Rand EB, Kim MS. Pathogenesis and Etiology of Unconjugated Hyperbillirubinemia in the newborn. UpToDate. 2015;(figure 1):1-10.
  4. National Institute for Health and Excellence. Neonatal jaundice. MidCity Place. 2010;5(May):457-75.
  5. Omeñaca Teres F, González Gallardo M. Ictericia neonatal. Pediatr Integr. 2015;18(6):367-74.
  6. Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: A systematic review and meta-analysis. PLoS One. 2015;10(2):1-16.
  7. Manrique R, Rivero A, Ortunio M, Rivas M, Cardozo Castellano de A R, Guevara Rivas H. Parto pretérmino en adolescentes. Revista de Obstetricia y Ginecología de Venezuela. 2008;68:141-143.
  8. Althabe F, Moore JL, Gibbons L, Berrueta M, Goudar SS, Chomba E, et al. Adverse maternal and perinatal outcomes in adolescent pregnancies: The Global Network’s Maternal Newborn Health Registry study. Reprod Health. Bio Med Central. 2015;12(Suppl 2):S8-S8.
  9. Ministerio de Salud y Protección Social. Indicadores Básicos 2014. Situación de Salud en Colombia [Internet]. 2015;1-140. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/Indicadores-basicos-salud-2014.pdf
  10. Scrafford CG, Mullany LC, Katz J, Khatry SK, Leclerq SC, Darmstadt GL, et al. Incidence of and risk factors for neonatal jaundice among newborns in southern Nepal. Trop Med Int Heal. 2013;18(11):1317-28.
  11. Rojas Feria P, Pavón Delgado A, Rosso González M, Losada Martínez A. Complicaciones a corto plazo de los recién nacidos pretérmino tardíos. An Pediatría. Elsevier; 2011 Sep 1;75(3):169-74.
  12. Najib KS, Saki F, Hemmati F, Inaloo S. Incidence, Risk Factors and Causes of Severe Neonatal Hyperbilirubinemia in the South of Iran (Fars Province). Iran Red Crescent Med J. 2013;15(3):260-3.
  13. Onyearugha CN, Onyire BN, Ugboma HAA. Neonatal jaundice: Prevalence and associated factors as seen in Federal Medical Centre Abakaliki, Southeast Nigeria. J Clin Med Res. 2011;3(3):40-5.
  14. Garosi E, Mohammadi F, Ranjkesh F. The relationship between
  15. neonatal jaundice and maternal and neonatal factors. Iran J Neonatol. 2016;7(1):37–40.
  16. Sachdeva A, Dutta AK. Advances in Pediatrics. 2 ed. New Delhi, Panamá, London: Jaypee Brothers Medical Publishers (P). Ltd; 2012. Disponible en: https://books.google.com.co/books?id=I2FHFyCaDeIC
  17. Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: Types, causes, clinical examinations, preventive measures and treatments: A narrative review article. Iranian Journal of Public Health. 2016;45(5):558-68.
  18. González AC, Uría RMA, Morán RA, López IB, Aguilar RD, Pérez MR. Hiperbilirrubinemia neonatal agravada. Rev Cubana Pediatr. 2010;82(3):13-9.
  19. Martínez de la Barrera LI. Ictericia neonatal-Hiperbilirrubinemia indirecta. Precop SCP [Internet]. 2012;12(2):38–45.
  20. Carrasco-Tejerina SH. Prevalencia de Ictericia Neonatal, (Hiperbilirrubinemia intermedia) y factores asociados en Recién nacidos a término en el Hospital II Ramón Castilla - EsSalud durante el año 2014. [Tesis pregrado] Lima, Perú: Universidad Ricardo Palma; 2016. Disponible en: http://cybertesis.urp.edu.pe/bitstream/urp/480/1/Carrasco_s.pdf
  21. Sánchez-Redondo Sánchez-Gabriel MD, Leante Castellanos JL, Benavente Fernández I, Pérez Muñuzuri A, Rite Gracia S, Ruiz Campillo CW, et al. Recomendaciones para la prevención, la detección y el manejo de la hiperbilirrubinemia en los recién nacidos con 35 o más semanas de edad gestacional. An Pediatría [Internet]. 2017; Available from: http://www.sciencedirect.com/science/article/pii/S1695403317301510
  22. Olusanya BO, Slusher TM. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review. World J Pediatr. 2015;11(4):293-9.
  23. Chou HC, Chen MH, Yang HI, Su YN, Hsieh WS, Chen CY, et al. 211 G to A variation of UDP-glucuronosyl transferase 1A1 gene and neonatal Breastfeeding jaundice. Pediatr Res. 2011;69(2):170-4.
  24. Fujiwara R, Maruo Y, Chen S, Tukey RH. Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia. Toxicol Appl Pharmacol. 2015 Nov;289(1):124-32.
  25. Hussain M, Irshad M, Kalim M, Ali L, Ali L. Glucose-6-phosphate dehydrogenase deficiency in jaundiced neonates. JPMI - J Postgrad Med Inst. 2010;24(2):121-6.
  26. Rao LB, Ahmed Z, Ozgonenel B. The Clinical Spectrum of ABO Incompatibility and Hemolytic Disease in the Newborn. Blood. 2015;120(21):1182.
  27. Maamouri G, Khatami F, Mohammadzadeh A. Hyperbilirubinemia and Neonatal Infection. International Journal of Pediatrics. 2013;1(1):5-12.
  28. Bhutani VK. Jaundice Due to Glucose-6-Phosphate Dehydrogenase Deficiency. Neoreviews. 2012;13(3):e166-77.
  29. Isa HM, Mohamed MS, Mohamed AM, Abdulla A, Abdulla F. Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency. Korean J Pediatr. 2017;60(4):106-11.

Downloads

Download data is not yet available.